Acute Leukaemia

Team leader: Dr David Taussig 

Aetiological Epidemiology

Team leader: Professor Richard Houlston 

Biology of Childhood Leukaemia

Team leader: Sir Mel Greaves 

Breast Cancer Collaborations

Team leader: Professor Andrew Tutt 

Breast Cancer Immunology

Team leader: Professor Alan Melcher 

Breast Cancer Radiotherapy

Team leader: Dr Anna Kirby 

Breast Cancer Research Bioinformatics Group

Breast Cancer Systemic Therapy Trials

Team leader: Dr Alicia Okines 

Breast Surgery Outcome Measures

Team leader: Jennifer Rusby 

Cancer and Genome Instability

Team leader: Professor Wojciech Niedzwiedz 

Cancer Biomarkers

Team leader: Professor Johann De Bono 

Cancer Dynamics

Team leader: Dr Stephen John Sammut 

Cancer Genomics

Team leader: Professor Richard Houlston 

Cancer Pharmacology and Stress Response

Team leader: Dr Olivia Rossanese 

Cancer Stem Cell

Team leader: Professor Axel Behrens 

Cell Death and Immunity

Team leader: Professor Pascal Meier 

Cell Division

Team leader: Professor Jonathon Pines 

Chromatin Biology

Team leader: Dr Alex Radzisheuskaya 

Chromosomal Translocations and Intracellular Antibody Therapeutics

Team leader: Professor Terence Rabbitts 

Chronic Lymphoid Malignancies: Clinical Trials and Translational Research (El-Sharkawi)

Team leader: Dr Dima El-Sharkawi

Clinical Academic Radiotherapy (Huddart)

Team leader: Professor Robert Huddart 

Clinical Cancer Epidemiology

Team leader: Professor Amy Berrington 

Clinical Pharmacodynamics Biomarker Group

Team leader: Professor Udai Banerji 

Clinical Pharmacology & Trials (including Drug Metabolism and Pharmacokinetics Group)

Team leader: Professor Udai Banerji 

Clinical Pharmacology Adaptive Therapy Group

Team leader: Professor Udai Banerji 

Computational Biology and Chemogenomics

Team leader: Professor Paul Workman 

Computational Imaging 

Team leader: Dr Matthew Blackledge 

Computational Pathology and Integrative Genomics

Team leader: Professor Janet Shipley 

Development and Cancer

Team leader: Dr Amanda Swain 

Drug Target Discovery

Team leader: Professor Andrew Tutt 

Dynamical Cell Systems

Team leader: Professor Chris Bakal 

Endocrine Control Mechanisms

Team leader: Professor Cathrin Brisken 

Epigenetics and Cancer

Team leader: Professor Kristian Helin 

Epigenetics and Genome Stability

Team leader: Professor Jessica Downs 

Evolutionary Genomics and Modelling

Team leader: Professor Andrea Sottoriva 

Functional Genetic Epidemiology

Team leader: Professor Olivia Fletcher 

Functional Genomics

Team leader: Dr Rachael Natrajan 

Functional Imaging

Team leader: Professor Christina Messiou 

Functional Proteomics

Team leader: Professor Jyoti Choudhary 

Functional Tumour Immunology

Team leader: Dr Esther Arwert 

Gastrointestinal Cancer Biology and Genomics

Team leader: Professor Nicola Valeri 

Gastrointestinal Clinical Oncology

Team leader: Dr Diana Tait 

Gene Function

Team leader: Professor Chris Lord 

Genome Replication

Team leader: Dr Gideon Coster 

Genome Stability and Innate Immunity

Team leader: Dr Christian Zierhut 

Genomics and Evolutionary Dynamics

Team leader: Professor Trevor Graham 

Glioma

Team leader: Professor Chris Jones 

Gynaecological Cancers (Systemic Therapy and Clinical Trials)

Team leader: Dr Susana Banerjee 

Gynaecological Oncology Surgery

Team leader: Thomas Ind 

Health Informatics

Team leader: Professor Ceire Costelloe 

Hit Discovery and Structural Design

Team leader: Dr Rob van Montfort 

ICR-CTSU Breast and Rare Cancers Trials

Team leader: Professor Judith Bliss 

ICR-CTSU Early Phase and Adaptive Trials

Team leader: Professor Christina Yap 

ICR-CTSU Integrative Genomic Analysis in Clinical Trials

Team leader: Dr Maggie Cheang 

ICR-CTSU Radiotherapy, Urology and Head and Neck Cancers Trials

Team leader: Professor Emma Hall 

Imaging for Radiotherapy Adaptation

Team leader: Dr Emma Harris 

Integrated Pathology

Team leader: Professor Manuel Salto-Tellez 

Lymphoma biology and imaging

Team leader: Dr Sunil Iyengar 

Macromolecular Structural Biology

Team leader: Professor Laurence Pearl 

Magnetic Resonance

Team leader: Professor Kevin Harrington 

Magnetic Resonance Imaging in Radiotherapy

Team leader: Dr Andreas Wetscherek 

Mechanisms and Regulation of pre-mRNA Splicing

Team leader: Professor Vlad Pena 

Medicinal Chemistry 1 

Team leader: Dr Gurdip Bhalay 

Medicinal Chemistry 3

Team leader: Dr Gary Newton 

Medicinal Chemistry 4 (including Analytical Chemistry)

Team leader: Professor Swen Hoelder 

Melanoma and Kidney Cancer

Team leaders: Professor James Larkin 
Professor Samra Turajlic 

Molecular and Systems Oncology

Team leader: Dr Paul Huang 

Molecular Cell Biology

Team leader: Professor Clare Isacke 

Molecular Mechanisms of Cell Cycle Regulation

Team leader: Dr Claudio Alfieri 

Molecular Oncology

Team leader: Professor Nicholas Turner 

Multimodality Molecular Imaging

Team leader: Dr Dimitra Darambara 

Myeloma Biology and Therapeutics

Team leader: Dr Charlotte Pawlyn 

Myeloma Group

Team leader: Professor Richard Houlston 

Myeloma Molecular Therapy 

Team leader: Dr Martin Kaiser 

Oncogenetics

Team leader: Professor Rosalind Eeles 

Paediatric & Adolescent Neuro-Oncology and Drug Development (Carceller)

Team leader: Dr Fernando Carceller 

Paediatric Solid Tumour Biology and Therapeutics

Team leader: Professor Louis Chesler 

Post-translational Modifications and Cell Proliferation

Team leader: Dr Jörg Mansfeld 

Preclinical Modelling of Paediatric Cancer Evolution

Team leader: Dr Alejandra Bruna 

Preclinical Molecular Imaging

Team leader: Dr Gabriela Kramer-Marek 

Pre-Clinical MRI

Team leader: Professor Simon Robinson 

Prostate and Bladder Cancer Research

Team leader: Professor Nick James 

Prostate Cancer Targeted Therapy Group

Team leader: Professor Johann De Bono 

Quantitative Biomedical Imaging

Team leader: Professor James O'Connor 

Radiation-enhanced Immunotherapy

Team leader: Dr Erik Wennerberg 

Radioisotope Physics

Team leader: Dr Glenn Flux 

Radiotherapy Physics Modelling

Team leader: Professor Uwe Oelfke 

RNA Biology and Molecular Therapeutics

Team leader: Dr Paul Clarke 

Sarcoma and Melanoma Surgery

Team leader: Professor Andrew Hayes 

Sarcoma Clinical Trials (R Jones)

Team leader: Dr Robin Jones 

Sarcoma Clinical Trials in Children and Young People

Team leader: Dr Julia Chisholm 

Sarcoma Molecular Pathology

Team leader: Professor Janet Shipley 

Short Linear Motif

Team leader: Dr Norman Davey 

Signal Transduction and Molecular Pharmacology

Team leader: Professor Paul Workman 

Signalling & Cancer Metabolism

Team leader: Dr George Poulogiannis 

Stereotactic and Precision Radiotherapy

Team leader: Professor Nicholas van As 

Structural Biology of Cell Signalling

Team leader: Professor Sebastian Guettler 

Structural Biology of DNA Repair Complexes

Team leader: Dr Basil Greber 

Systems and Precision Cancer Medicine

Team leader: Dr Anguraj Sadanandam 

Systems Chemical Biology

Team leader: Dr Albert Antolin 

Target Biology and Genomic Instability

Team leader: Dr Olivia Rossanese 

Target Evaluation and Molecular Therapeutics

Team leader: Dr Olivia Rossanese 

Target Validation and DNA Damage Response

Team leader: Professor Andrew Tutt 

Targeted Therapy

Team leader: Professor Kevin Harrington 

Telomere Biology

Team leader: Dr Max Douglas 

The Adult Drug Development Unit at the ICR and the RM

Team leader: Professor Johann De Bono 

Therapeutic Ultrasound

Team leader: Professor Gail Ter Haar 

Thoracic Oncology

Team leader: Professor Sanjay Popat 

Thoracic Oncology Immunotherapy Group

Team leader: Dr Astero Klampatsa 

Translational Breast Radiobiology

Team leader: Dr Navita Somaiah 

Translational Genetics

Team leader: Professor Clare Turnbull 

Translational Immunotherapy

Team leader: Professor Alan Melcher 

Translational Oncogenomics

Team leader: Professor Janet Shipley 

Translational Sarcoma, Melanoma and Rare Tumour Surgery

Team leader: Myles Smith 

Translational Therapeutic Radiography

Team leader: Dr Helen McNair 

Translational Therapeutics

Team leader: Dr Adam Sharp 

Tumour Functional Heterogeneity

Team leader: Dr Marco Bezzi 

Ultrasound and Optical Imaging

Team leader: Professor Jeffrey Bamber 

Uro-oncology Clinical Trials

Team leader: Dr Alison Tree 

Vannini Group

Team leader: Professor Laurence Pearl 